Project-003

UTMB CTSA枢纽劳动力发展（WFD）的目标是创建和维持一个多样化，强大的 多学科的劳动力与技能，知识和制度环境所必需的持续 改进临床和转化生物医学研究。新的和现有的基于能力的 下文所述的教育和培训机会的设计是为了便于获得、切合实际和解决 通过与其他U 54、TL 1和KL 2员工充分整合，满足所有职业阶段学习者的特定需求 发展的组成部分，并通过参与不仅医生科学家和翻译科学家， 研究协调员、护士和其他专职医疗人员。与我们的战略目标保持一致 CTSA和NCATS优先考虑的活动领域，我们将提供现场和在线机会， 团队科学培训（例如，TeamMAPPS）、团队领导（例如，领导力挑战计划），medicaland 生物信息学（例如，医学信息学基础），创业（例如，TREx），社区参与 研究，以及与人类受试者研究和临床相关的监管和伦理问题 试验（例如，临床研究实践）。我们的临床和转化研究试点（CTRP）计划 汇集研究资源并对其进行投资，以推进基于团队的科学， 和国家优先事项。我们的CTRP计划将继续丰富我们CTSA内部的新合作， 与其他大学和CTSA计划合作。我们的目标是奖励试点项目， CTSA的优先领域包括翻译新发现，以改善患者护理，同时了解和 解决转换过程的每个阶段的组织挑战（即，执行 科学）。为了实现这些目标，我们的CTRP计划将利用我们的导师，多学科， 团队和独特的学术伙伴关系。我们的临床试验工作室将协助研究人员，作为一个前门， 机制，以促进严格的研究设计和应用，通过确保我们的新的临床研究者， 具有使用良好临床实践（GCP）标准进行研究的基本技能。此外，本发明还 CTRP计划旨在包括社区参与核心，以便最好地传播翻译 并将研究成果推广到农村地区。每年，CTRP飞行员将在 以下类别，1）试点临床试验[每年1 - 3次]，代表了成功的翻译小说 设备和治疗方法的发现，2）与UTMB学术合作伙伴共同赞助CTSA试点赠款[两个 - 每年四次]和3）支持新的MTT [每年一次]，旨在为以下方面提供独特的机会： 科学进步和团队成长。此外，凭单的管理将特别侧重于新的 研究人员进行可行性试验。所有WDF和CTRP进度的评估将使用通用指标 (e.g.,新的手稿，校外资金和知识产权）以及其他有效的评估 工具和可交付成果。

The UTMB CTSA hub workforce development (WFD) objective is to create and sustain a diverse, robust multidisciplinary workforce with the skills, knowledge, and institutional environment necessary for continuous improvement in clinical and translational biomedical research. The new and existing competency-based educational and training opportunities described below are designed to be accessible, relevant and address learner-specific needs at all career stages, by being fully integrated with other U54, TL1 and KL2 workforce development components, and by engaging not only physician scientists and translational scientists, but also research coordinators, nurses, and other allied health professionals. Aligned with the strategic goals of our CTSA and domains of activity prioritized by NCATS, we will offer both on-site and on-line opportunities for training in team science (e.g., TeamMAPPS), team leadership (e.g., Leadership Challenge Program), medicaland bio-informatics (e.g., Foundations of Medical Informatics), entrepreneurship (e.g., TREx), communityengaged research, and the regulatory and ethical issues associated with human-subjects research and clinical trials (e.g.,Clinical Research Practicums). Our Clinical and Translational Research Pilot (CTRP) program brings together research resources and invests in them to advance team-based science that is aligned with institutional and national priorities. Our CTRP program continues to enrich new collaborations within our CTSA as well as to collaborate with other Universities and CTSA programs. Our goal is to award pilot projects that aptly reflect CTSA priority areas including translation of novel discoveries to improve patient care while understanding and addressing the organizational challenges underlying each stage of the translational process (i.e., implementation science). Towards these ends, our CTRP program will leverage the diverse strengths of our mentors, multidisciplinary teams and unique academic partnerships. Our clinical trials studio will assist investigators, as a frontdoor mechanism, to facilitate rigorous study design and application, by ensuing that our new clinical investigators have the essential skills to conduct their research using good clinical practice (GCP) standards. Additionally, the CTRP program will aim to include community engagement core in order to best disseminate translational findings and to expand studies into the rural areas. Each year, CTRP pilots will be evaluated and awarded in the following categories, 1) the pilot clinical trials [one - three per year] that represent successful translation for novel discovery of devices and therapeutics, 2) co-sponsored CTSA pilot grants with UTMB academic partners [two – four per year] and 3) to support a new MTT [one per year] that are designed to foster unique opportunities for scientific advancement and team growth. Additionally, vouchers will be administered with a special focus on new investigators to conduct feasibility trials. Evaluation of all WDF and CTRP progress will use common metrics (e.g., new manuscripts, extramural funding, and intellectual property) as well as other validated assessment tools and deliverables.